Literature DB >> 25458544

[Assessment and treatment of acute pancreatitis. Position document of the Catalan Society of Gastroenterology, Catalan Society of Surgery and Catalan Society of the Pancreas].

Jaume Boadas1, Joaquin Balsells2, Juli Busquets3, Antoni Codina-B4, Anna Darnell5, Francisco Garcia-Borobia6, Àngels Ginés7, Joan Gornals8, Guillem Gruartmoner9, Lucas Ilzarbe10, Xavier Merino11, Lluís Oms12, Ignasi Puig13, Valentí Puig-Diví14, Eva Vaquero7, Francesc Vida13, Xavier Molero15.   

Abstract

The incidence of acute pancreatitis (AP) is increasing. AP is one of the gastrointestinal diseases that most frequently requires hospital admission in affected individuals. In the last few years, considerable scientific evidence has led to substantial changes in the medical and surgical treatment of this disease. New knowledge of the physiopathology of AP indicates that its severity is influenced by its systemic effects (organ failure), especially if the disease is persistent, and also by local complications (fluid collections or necrosis), especially if these become infected. Treatment should be personalized and depends on the patient's clinical status, the location of the necrosis, and disease stage.
Copyright © 2014 Elsevier España, S.L.U. and AEEH y AEG. All rights reserved.

Entities:  

Keywords:  Acute pancreatitis; Necrosis pancreática; Pancreatic necrosis; Pancreatitis aguda; Tratamiento; Treatment

Mesh:

Year:  2014        PMID: 25458544     DOI: 10.1016/j.gastrohep.2014.09.006

Source DB:  PubMed          Journal:  Gastroenterol Hepatol        ISSN: 0210-5705            Impact factor:   2.102


  1 in total

1.  Multicenter study of plastic vs. self-expanding metal stents in endoscopic ultrasound-guided drainage of walled-off pancreatic necrosis - PROMETHEUS: a randomized controlled trial protocol.

Authors:  Joan B Gornals; Manuel Perez-Miranda; Enrique Vazquez-Sequeiros; Juan Vila; José M Esteban; Ferran Gonzalez-Huix; Carlos Guarner-Argente; Andres Sanchez-Yague; Alvaro Teran; Francesc Bas-Cutrina; Carlos De La Serna; Ana Garcia De Paredes; Raquel Ballester; Julio Velasquez-Rodriguez; Silvia Salord; Cristian Tebe; Pilar Hereu; Sebas Videla
Journal:  Trials       Date:  2019-12-30       Impact factor: 2.279

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.